MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
4.801
-0.009 (-0.19%)
Oct 30, 2025, 9:03 AM EDT - Market open
MDxHealth Market Cap
MDxHealth has a market cap or net worth of $237.63 million as of October 30, 2025. Its market cap has increased by 148.77% in one year.
Market Cap
237.63M
Enterprise Value
289.28M
1-Year Change
148.77%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since the IPO on May 12, 2017, MDxHealth's market cap has decreased from $269.23M to $237.63M, a decrease of -11.74%. That is a compound annual growth rate of -1.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 238.08M | 112.44% |
| Dec 31, 2024 | 112.07M | 4.24% |
| Dec 29, 2023 | 107.52M | 659,987.71% |
| Dec 29, 2022 | 16.29K | -99.98% |
| Dec 30, 2020 | 91.60M | 18.07% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.09B |
| Johnson & Johnson | 457.53B |
| AbbVie | 403.09B |
| UnitedHealth Group | 329.67B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Merck & Co. | 219.90B |